ImmuPharma (LON:IMM) Stock Price Down 27.1% – Time to Sell?

ImmuPharma plc (LON:IMM)’s share price traded down 27.1% during mid-day trading on Monday . The stock traded as low as GBX 6.52 and last traded at GBX 7.12. 25,940,547 shares changed hands during mid-day trading, an increase of 225% from the average session volume of 7,976,025 shares. The stock had previously closed at GBX 9.76.

ImmuPharma Price Performance

The firm’s 50 day moving average price is GBX 10.80 and its 200-day moving average price is GBX 5.87. The stock has a market cap of £37.20 million, a P/E ratio of -8.31 and a beta of 1.53.

ImmuPharma Company Profile

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.